Single Biggest Cancer Dictionary in the World
What is MET/VEGFR-2 inhibitor GSK1363089?
Pronunciation: /mɛt vegfr* tu ˌɪnˈhɪbətər gsk* wən ˈmɪljən, θri ˈhənərd ənd sixty-three* ˈθaʊzənd ənd eighty-nine*/
MET/VEGFR-2 inhibitor GSK1363089
Definition
A substance being studied in the treatment of cancer. MET/VEGFR-2 inhibitor GSK1363089 blocks enzymes involved in the growth and spread of tumor cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called foretinib and XL880.